Sonnet BioTherapeutics
SONN
SONN
9 hedge funds and large institutions have $2.02M invested in Sonnet BioTherapeutics in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.26%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
2
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TDC
1
Thompson Davis & Co
Richmond,
Virginia
|
$675K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$2K |
Top Sellers
| 1 |
1
Hudson Bay Capital Management
Stamford,
Connecticut
|
$38K |
| 2 |
2
Citigroup
New York
|
$0 |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$81K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Millennium Management
New York
| $836K | 222,222 | – | – |
|
|
TDC
2
Thompson Davis & Co
Richmond,
Virginia
| $675K | 179,432 | +42,646 | +31% |
|
|
BIT
3
BlackRock Institutional Trust
San Francisco,
California
| $213K | 56,692 | – | – |
|
|
CDH
4
Charles D. Hyman
| $167K | 44,444 | – | – |
|
|
5
Bank of America
Charlotte,
North Carolina
| $81K | 21,428 | -10 | -0% |
|
|
6
Hudson Bay Capital Management
Stamford,
Connecticut
| $38K | 10,000 | -30,000 | -75% |
|
|
U
7
UBS
Zurich,
Switzerland
| $8K | 2,000 | – | – |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $2K | 400 | +400 | New |
|
|
9
Citigroup
New York
| – | – | -750 | Closed |
|
10
Morgan Stanley
New York
| $0 | 9 | +9 | New |
|